Member login

Forgot Password?

By using the members area you have already agreed to share your personal information with the BBA so that you can access the members materials. We will store your details only as long as you are a member. Your personal information will not be shared any affiliated companies or third parties. For more information about our Privacy Policy, click here.

Return to login
Better access. Better health
Read our guide to Generic and biosimilars medicines market and pricing
Better access to high quality biological medicines
The British Biosimilars Association (BBA) is the expert sector group of the British Generic Manufacturers Association (BGMA) exclusively focused on biosimilars

The British Biosimilars Association (BBA) is the expert sector group of the British Generic Manufacturers Association (BGMA) exclusively focused on biosimilars.

The members of the BBA ensure access to high quality, safe and effective biosimilar medicines for UK patients. As industry experts, we partner with patients’ representatives, healthcare professionals, regulators and payers to increase understanding and to drive a sustainable environment for the development, production and continuing optimised use of biosimilar medicines across the UK.

For more information about Biosimilars, please take a look at NHS England’s ‘What is a Biosimilar’ document.

Twitter

21.04.2020
RT @Britishgenerics: Please click below to see a video message from the BGMA's chair Tim de Gavre on how the generic medicines sector is supporting the NHS to get vital medicines during a time of unprecedented demand. #NHS https://t.co/Z4rJ2zHsCO
13.04.2020
Please submit your ideas to help the Government hit its target of 100k tests a day https://t.co/HavK0yaFwy
13.04.2020
RT @JimBethell: Hitting 100k tests a day is a massive target. We've huge obstacles to overcome. There are four major challenges. If you can help, please lodge your answers on this crowd-sourcing site from @RCPath @BIVDA @BIA_UK @DHSCgovuk. We need your help. ???????????????? https://t.c
13.04.2020
RT @BIA_UK: #TestingMethods2020 - please share our new open platform developed with the Department of Health and Social Care, British In-vitro Diagnostics Association and the Royal College of Pathologists seeking answers to key PCR testing questions https://t.co/15qUujJJEq
10.02.2020
Pleased to announce that @Teva_UK 's Dr Andrew Ellis has been announced as the new chair of the British Biosimilars Association. https://t.co/AUipO5QT4G